PatientMatch — Privacy-first clinical trial discovery

44 trials

Ulcerative ColitisRecruiting now

Showing 1–24 of 44 trials

Enrolling now

Nationwide

Icotrokinra Trial for Ulcerative Colitis

Janssen Research & Development, LLC

Ph 3·~6yr·47 sites in AZ, CA, CO +17

Enrolling now

Check if I qualify View study

Nationwide

Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

Mayo Clinic

Device·~3yr·1 site in MN

Enrolling now

Check if I qualify View study

Nationwide

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease

Takeda

Ph 4·~3yr·98 sites in AL, AR, AZ +29

Enrolling now

Check if I qualify View study

Nationwide

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Takeda

Ph 3·~2yr·11 sites in CA, IL, MI +5

Enrolling now

Check if I qualify View study

Nationwide

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Takeda

Ph 4·~3yr·40 sites in AL, AZ, CA +19

Enrolling now

Check if I qualify View study

Nationwide

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Sanofi

Ph 2·~3yr·18 sites in AZ, CT, FL +7

Enrolling now

Check if I qualify View study

Nationwide

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

AbbVie

Ph 3·~9yr·6 sites in AZ, FL, GA +3

Enrolling now

Check if I qualify View study

Nationwide

Fermented Food-Supplemented Diet in Ulcerative Colitis

Stanford University

~7yr·1 site in CA

Enrolling now

Check if I qualify View study

Nationwide

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis

Eli Lilly and Company

Ph 2·~3yr·41 sites in AZ, CA, CO +16

Enrolling now

Check if I qualify View study

Nationwide

Mirikizumab and Tirzepatide Trial

Eli Lilly and Company

Ph 3·~3yr·37 sites in AL, CA, FL +20

Enrolling now

Check if I qualify View study

Nationwide

2'-FL Dietary Supplement Trial for IBD

Children's Hospital Medical Center, Cincinnati

Ph 1/2·~8yr·3 sites in CT, OH

Enrolling now

Check if I qualify View study

Nationwide

Study of Novel Therapeutics for Acute Remedy of Colitis

Brigham and Women's Hospital

Ph 2·~1.5yr·1 site in MA

Enrolling now

Check if I qualify View study

Nationwide

Study to Evaluate Budesonide for Ulcerative Colitis in Children

Bausch Health Americas, Inc.

Ph 4·~4yr·4 sites in CA, IN, NC +1

Enrolling now

Check if I qualify View study

Nationwide

Treat-to-Target Endoscopic Remission in IBD Patients

University of California, San Diego

~6yr·22 sites in CA, CO, CT +12

Enrolling now

Check if I qualify View study

Nationwide

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Takeda

Ph 3·~8yr·14 sites in AZ, CA, GA +10

Enrolling now

Check if I qualify View study

Nationwide

Extension Study of Long-term Safety and Efficacy of Tulisokibart

Merck Sharp & Dohme LLC

Ph 3·~13yr·12 sites in CT, MI, MO +4

Enrolling now

Check if I qualify View study

Nationwide

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Rise Therapeutics LLC

Ph 1·~3yr·4 sites in CA, FL, MN

Enrolling now

Check if I qualify View study

Nationwide

Long-term Study of Guselkumab in Children with Arthritis

Janssen Research & Development, LLC

Ph 3·~7yr·4 sites in GA, IN, OH +1

Enrolling now

Check if I qualify View study

Nationwide

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Sanofi

Ph 3·~7yr·9 sites in FL, LA, MO +3

Enrolling now

Check if I qualify View study

Nationwide

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Spyre Therapeutics, Inc.

Ph 2·~3yr·21 sites in CA, CO, FL +10

Enrolling now

Check if I qualify View study

Nationwide

A Study on TAK-279 for Ulcerative Colitis

Takeda

Ph 2·~3yr·16 sites in CA, FL, GA +7

Enrolling now

Check if I qualify View study

Nationwide

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

AbbVie

Ph 3·~3yr·74 sites in AL, AZ, CA +24

Enrolling now

Check if I qualify View study

Nationwide

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

Gilead Sciences

Ph 2·~3yr·53 sites in AZ, CA, FL +12

Enrolling now

Check if I qualify View study

Nationwide

Tailored Anti-Inflammatory Diet for Americans With Ulcerative Colitis (UC)

University of Miami

Lifestyle·~5yr·1 site in FL

Enrolling now

Check if I qualify View study